Nidia Quillinan
Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Ischemia | 15 | 2025 | 321 | 3.160 |
Why?
| Heart Arrest | 12 | 2025 | 321 | 2.210 |
Why?
| Purkinje Cells | 4 | 2019 | 71 | 1.650 |
Why?
| Hippocampus | 19 | 2025 | 874 | 1.640 |
Why?
| Neurons | 16 | 2025 | 1511 | 1.220 |
Why?
| Recovery of Function | 6 | 2025 | 642 | 1.200 |
Why?
| CA1 Region, Hippocampal | 4 | 2024 | 52 | 1.100 |
Why?
| Stroke | 7 | 2023 | 1071 | 1.080 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 7 | 2025 | 185 | 1.070 |
Why?
| Long-Term Potentiation | 5 | 2025 | 197 | 1.040 |
Why?
| Gonadal Steroid Hormones | 2 | 2025 | 131 | 1.000 |
Why?
| TRPM Cation Channels | 7 | 2024 | 77 | 0.960 |
Why?
| Cardiopulmonary Resuscitation | 7 | 2025 | 232 | 0.920 |
Why?
| Neuroprotection | 3 | 2020 | 38 | 0.780 |
Why?
| Cerebellar Diseases | 1 | 2022 | 23 | 0.760 |
Why?
| Mice, Inbred C57BL | 22 | 2025 | 5440 | 0.730 |
Why?
| Neurotoxicity Syndromes | 5 | 2025 | 23 | 0.710 |
Why?
| Receptors, N-Methyl-D-Aspartate | 4 | 2020 | 212 | 0.680 |
Why?
| Animals | 51 | 2025 | 35361 | 0.660 |
Why?
| Long-Term Synaptic Depression | 2 | 2018 | 56 | 0.650 |
Why?
| Protective Agents | 1 | 2019 | 39 | 0.640 |
Why?
| Calmodulin | 1 | 2019 | 76 | 0.640 |
Why?
| Neuroprotective Agents | 7 | 2020 | 122 | 0.610 |
Why?
| Anesthetics | 3 | 2022 | 66 | 0.540 |
Why?
| Excitatory Postsynaptic Potentials | 1 | 2016 | 120 | 0.510 |
Why?
| Mice | 34 | 2025 | 16937 | 0.500 |
Why?
| Brain Injuries | 2 | 2021 | 468 | 0.500 |
Why?
| Androgens | 2 | 2014 | 177 | 0.490 |
Why?
| Anesthetics, Inhalation | 3 | 2025 | 27 | 0.490 |
Why?
| Estradiol | 1 | 2018 | 494 | 0.480 |
Why?
| Calcium | 2 | 2019 | 1213 | 0.440 |
Why?
| Narcotics | 2 | 2011 | 47 | 0.430 |
Why?
| Receptors, Opioid, mu | 2 | 2011 | 65 | 0.420 |
Why?
| Morphine | 3 | 2011 | 137 | 0.420 |
Why?
| Receptors, GABA-A | 5 | 2024 | 127 | 0.390 |
Why?
| Disease Models, Animal | 11 | 2022 | 4063 | 0.390 |
Why?
| Neuronal Plasticity | 6 | 2021 | 280 | 0.380 |
Why?
| Methadone | 2 | 2011 | 92 | 0.350 |
Why?
| Memory | 2 | 2023 | 255 | 0.320 |
Why?
| Sex Characteristics | 5 | 2020 | 737 | 0.310 |
Why?
| Burns | 2 | 2023 | 286 | 0.310 |
Why?
| Male | 29 | 2025 | 63681 | 0.290 |
Why?
| Brain | 6 | 2021 | 2679 | 0.260 |
Why?
| Ischemia | 2 | 2020 | 406 | 0.260 |
Why?
| Methyl Ethers | 2 | 2023 | 10 | 0.250 |
Why?
| Brain Injuries, Traumatic | 2 | 2023 | 341 | 0.250 |
Why?
| Animals, Newborn | 6 | 2025 | 835 | 0.250 |
Why?
| Synapses | 4 | 2022 | 400 | 0.240 |
Why?
| Cell Death | 6 | 2020 | 354 | 0.240 |
Why?
| Microglia | 2 | 2025 | 235 | 0.230 |
Why?
| Rats, Sprague-Dawley | 7 | 2025 | 2406 | 0.230 |
Why?
| Infarction, Middle Cerebral Artery | 2 | 2023 | 39 | 0.230 |
Why?
| Ovariectomy | 1 | 2025 | 137 | 0.230 |
Why?
| Glycosaminoglycans | 1 | 2023 | 84 | 0.210 |
Why?
| Lipopolysaccharides | 2 | 2025 | 875 | 0.200 |
Why?
| Rats | 7 | 2025 | 5500 | 0.200 |
Why?
| Inflammation | 3 | 2025 | 2736 | 0.190 |
Why?
| Nerve Net | 2 | 2022 | 260 | 0.190 |
Why?
| Neurocognitive Disorders | 1 | 2022 | 26 | 0.190 |
Why?
| Anesthetics, General | 1 | 2022 | 8 | 0.190 |
Why?
| Ketamine | 1 | 2022 | 85 | 0.190 |
Why?
| Signal Transduction | 6 | 2024 | 4925 | 0.180 |
Why?
| Presynaptic Terminals | 1 | 2021 | 83 | 0.180 |
Why?
| Astrocytes | 1 | 2022 | 201 | 0.170 |
Why?
| Cell-Derived Microparticles | 1 | 2021 | 67 | 0.170 |
Why?
| Pregnanediones | 1 | 2020 | 7 | 0.170 |
Why?
| Phosphorylation | 6 | 2023 | 1713 | 0.170 |
Why?
| Cerebellum | 1 | 2022 | 219 | 0.170 |
Why?
| Mice, Knockout | 8 | 2019 | 2871 | 0.170 |
Why?
| Death-Associated Protein Kinases | 1 | 2020 | 11 | 0.170 |
Why?
| Sex Factors | 4 | 2018 | 1968 | 0.170 |
Why?
| Age Factors | 3 | 2022 | 3144 | 0.170 |
Why?
| Solute Carrier Family 12, Member 2 | 1 | 2019 | 8 | 0.160 |
Why?
| Genes, Immediate-Early | 1 | 2019 | 20 | 0.160 |
Why?
| Brain-Derived Neurotrophic Factor | 2 | 2018 | 114 | 0.160 |
Why?
| Cations | 1 | 2019 | 80 | 0.160 |
Why?
| Receptors, AMPA | 2 | 2018 | 141 | 0.160 |
Why?
| Symporters | 1 | 2019 | 56 | 0.160 |
Why?
| Extracellular Vesicles | 1 | 2021 | 130 | 0.160 |
Why?
| Steroids | 1 | 2020 | 158 | 0.160 |
Why?
| Alzheimer Disease | 1 | 2025 | 519 | 0.160 |
Why?
| Chlorides | 1 | 2019 | 139 | 0.150 |
Why?
| Cognition Disorders | 3 | 2020 | 505 | 0.150 |
Why?
| Holoenzymes | 1 | 2018 | 22 | 0.150 |
Why?
| Hypnotics and Sedatives | 1 | 2020 | 175 | 0.150 |
Why?
| Apoptosis | 4 | 2025 | 2503 | 0.150 |
Why?
| Female | 16 | 2025 | 68776 | 0.140 |
Why?
| Peptide Fragments | 1 | 2021 | 692 | 0.140 |
Why?
| Neurodevelopmental Disorders | 1 | 2020 | 156 | 0.140 |
Why?
| Calcium Signaling | 1 | 2019 | 250 | 0.140 |
Why?
| Child Development | 1 | 2022 | 457 | 0.140 |
Why?
| Receptors, Glutamate | 1 | 2016 | 22 | 0.130 |
Why?
| Sirtuin 2 | 1 | 2015 | 24 | 0.120 |
Why?
| Peptides | 2 | 2023 | 925 | 0.120 |
Why?
| Membrane Glycoproteins | 1 | 2018 | 474 | 0.120 |
Why?
| Microbiota | 1 | 2023 | 730 | 0.120 |
Why?
| Membrane Proteins | 1 | 2021 | 1119 | 0.120 |
Why?
| Calbindins | 1 | 2014 | 5 | 0.120 |
Why?
| Dizocilpine Maleate | 1 | 2014 | 19 | 0.120 |
Why?
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2014 | 10 | 0.110 |
Why?
| Cell Communication | 1 | 2016 | 301 | 0.110 |
Why?
| Protein-Tyrosine Kinases | 1 | 2018 | 432 | 0.110 |
Why?
| Tissue Culture Techniques | 1 | 2014 | 74 | 0.110 |
Why?
| Excitatory Amino Acid Antagonists | 1 | 2014 | 100 | 0.110 |
Why?
| Cognitive Dysfunction | 1 | 2019 | 346 | 0.110 |
Why?
| Receptors, Adrenergic, alpha-2 | 1 | 2013 | 17 | 0.110 |
Why?
| Adrenergic alpha-2 Receptor Agonists | 1 | 2013 | 24 | 0.110 |
Why?
| Dexmedetomidine | 1 | 2013 | 43 | 0.100 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2013 | 94 | 0.100 |
Why?
| Humans | 15 | 2025 | 129650 | 0.100 |
Why?
| Piperidines | 1 | 2014 | 199 | 0.100 |
Why?
| Oxidative Stress | 2 | 2016 | 1269 | 0.100 |
Why?
| Spinal Cord Ischemia | 1 | 2013 | 56 | 0.100 |
Why?
| Mice, Transgenic | 4 | 2011 | 2119 | 0.100 |
Why?
| Locus Coeruleus | 2 | 2008 | 22 | 0.090 |
Why?
| Extracorporeal Membrane Oxygenation | 1 | 2015 | 282 | 0.090 |
Why?
| beta-Arrestin 2 | 1 | 2011 | 7 | 0.090 |
Why?
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2011 | 9 | 0.090 |
Why?
| beta-Arrestins | 1 | 2011 | 14 | 0.090 |
Why?
| Arrestins | 1 | 2011 | 14 | 0.090 |
Why?
| Models, Animal | 1 | 2013 | 376 | 0.090 |
Why?
| Spinal Cord | 1 | 2013 | 356 | 0.090 |
Why?
| Reperfusion Injury | 1 | 2013 | 272 | 0.090 |
Why?
| Calcineurin | 2 | 2023 | 98 | 0.090 |
Why?
| Oxygen | 2 | 2012 | 915 | 0.090 |
Why?
| Brain Chemistry | 1 | 2011 | 118 | 0.090 |
Why?
| Nerve Tissue Proteins | 1 | 2014 | 570 | 0.090 |
Why?
| Magnetic Resonance Imaging | 1 | 2022 | 3408 | 0.080 |
Why?
| Estrogens | 1 | 2013 | 347 | 0.080 |
Why?
| Endocytosis | 1 | 2011 | 163 | 0.080 |
Why?
| Cognition | 1 | 2017 | 1123 | 0.080 |
Why?
| Dendritic Spines | 2 | 2020 | 65 | 0.080 |
Why?
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2008 | 8 | 0.080 |
Why?
| Time Factors | 6 | 2017 | 6556 | 0.070 |
Why?
| Membrane Potentials | 1 | 2008 | 293 | 0.070 |
Why?
| RGS Proteins | 1 | 2006 | 16 | 0.070 |
Why?
| Retinal Rod Photoreceptor Cells | 1 | 2006 | 14 | 0.070 |
Why?
| Child | 4 | 2023 | 20883 | 0.060 |
Why?
| Arrestin | 1 | 2006 | 14 | 0.060 |
Why?
| Rhodopsin | 1 | 2006 | 10 | 0.060 |
Why?
| Aging | 2 | 2013 | 1776 | 0.060 |
Why?
| HEK293 Cells | 2 | 2020 | 697 | 0.060 |
Why?
| Mitochondria | 2 | 2022 | 877 | 0.060 |
Why?
| Decorin | 1 | 2023 | 7 | 0.060 |
Why?
| GABAergic Neurons | 1 | 2024 | 30 | 0.050 |
Why?
| Alternative Splicing | 1 | 2006 | 218 | 0.050 |
Why?
| Chondroitin Sulfates | 1 | 2023 | 35 | 0.050 |
Why?
| Dose-Response Relationship, Drug | 2 | 2020 | 2012 | 0.050 |
Why?
| Postoperative Complications | 1 | 2015 | 2483 | 0.050 |
Why?
| Aspartic Acid Endopeptidases | 1 | 2023 | 27 | 0.050 |
Why?
| Neural Inhibition | 1 | 2024 | 159 | 0.050 |
Why?
| Mossy Fibers, Hippocampal | 1 | 2022 | 11 | 0.050 |
Why?
| Amyloid beta-Protein Precursor | 1 | 2023 | 62 | 0.050 |
Why?
| Extracellular Matrix Proteins | 1 | 2023 | 144 | 0.050 |
Why?
| Amyloid Precursor Protein Secretases | 1 | 2023 | 80 | 0.050 |
Why?
| Caspase 9 | 1 | 2022 | 56 | 0.050 |
Why?
| Protein Transport | 2 | 2018 | 428 | 0.050 |
Why?
| Chemokines | 1 | 2023 | 226 | 0.050 |
Why?
| Dysbiosis | 1 | 2023 | 169 | 0.050 |
Why?
| Caspase 1 | 1 | 2022 | 143 | 0.050 |
Why?
| Organ Culture Techniques | 1 | 2021 | 154 | 0.050 |
Why?
| Ligands | 1 | 2023 | 622 | 0.050 |
Why?
| Colon | 1 | 2023 | 254 | 0.050 |
Why?
| Caspase 3 | 1 | 2022 | 245 | 0.050 |
Why?
| Myelin Sheath | 1 | 2023 | 160 | 0.050 |
Why?
| Gene Expression | 1 | 2006 | 1472 | 0.050 |
Why?
| Oligodendroglia | 1 | 2023 | 166 | 0.040 |
Why?
| Interleukin-18 | 1 | 2022 | 237 | 0.040 |
Why?
| Genetic Variation | 1 | 2006 | 937 | 0.040 |
Why?
| Swine | 1 | 2023 | 760 | 0.040 |
Why?
| Synaptic Transmission | 1 | 2022 | 273 | 0.040 |
Why?
| Mammals | 1 | 2022 | 271 | 0.040 |
Why?
| Amyloid beta-Peptides | 1 | 2023 | 213 | 0.040 |
Why?
| GABA-A Receptor Agonists | 1 | 2020 | 17 | 0.040 |
Why?
| Neurotoxins | 1 | 2020 | 28 | 0.040 |
Why?
| Inhibitory Postsynaptic Potentials | 1 | 2020 | 40 | 0.040 |
Why?
| Patch-Clamp Techniques | 2 | 2012 | 279 | 0.040 |
Why?
| Reflex, Righting | 1 | 2019 | 11 | 0.040 |
Why?
| Propofol | 1 | 2020 | 60 | 0.040 |
Why?
| Models, Theoretical | 1 | 2023 | 547 | 0.040 |
Why?
| Glycogen Synthase Kinase 3 beta | 1 | 2019 | 68 | 0.040 |
Why?
| Thalamic Nuclei | 1 | 2018 | 10 | 0.040 |
Why?
| Glutamic Acid | 1 | 2020 | 237 | 0.040 |
Why?
| Resuscitation | 1 | 2020 | 237 | 0.040 |
Why?
| Blotting, Western | 2 | 2012 | 1205 | 0.030 |
Why?
| Epigenesis, Genetic | 1 | 2022 | 613 | 0.030 |
Why?
| Prefrontal Cortex | 1 | 2020 | 305 | 0.030 |
Why?
| Bacteria | 1 | 2023 | 821 | 0.030 |
Why?
| Exons | 1 | 2018 | 342 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 287 | 0.030 |
Why?
| gamma-Aminobutyric Acid | 1 | 2017 | 169 | 0.030 |
Why?
| Memory Disorders | 1 | 2017 | 168 | 0.030 |
Why?
| Protein Domains | 1 | 2018 | 253 | 0.030 |
Why?
| Glucose | 2 | 2012 | 1003 | 0.030 |
Why?
| Brain Infarction | 1 | 2016 | 23 | 0.030 |
Why?
| Up-Regulation | 1 | 2019 | 840 | 0.030 |
Why?
| Protein Isoforms | 1 | 2018 | 391 | 0.030 |
Why?
| Endothelial Cells | 1 | 2021 | 749 | 0.030 |
Why?
| Furans | 1 | 2015 | 23 | 0.030 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 398 | 0.030 |
Why?
| Learning | 1 | 2019 | 403 | 0.030 |
Why?
| Photic Stimulation | 2 | 2006 | 242 | 0.030 |
Why?
| Monitoring, Intraoperative | 1 | 2015 | 47 | 0.030 |
Why?
| DNA Methylation | 1 | 2020 | 607 | 0.030 |
Why?
| Calcium Channel Agonists | 1 | 2014 | 12 | 0.030 |
Why?
| Cells, Cultured | 2 | 2013 | 4083 | 0.030 |
Why?
| Quinolines | 1 | 2015 | 156 | 0.030 |
Why?
| Cerebral Cortex | 1 | 2018 | 437 | 0.030 |
Why?
| In Vitro Techniques | 2 | 2006 | 1085 | 0.030 |
Why?
| Cytokines | 1 | 2022 | 2017 | 0.030 |
Why?
| Hematoxylin | 1 | 2013 | 5 | 0.030 |
Why?
| Eosine Yellowish-(YS) | 1 | 2013 | 9 | 0.030 |
Why?
| Transfection | 1 | 2016 | 911 | 0.030 |
Why?
| Retina | 2 | 2006 | 279 | 0.030 |
Why?
| Fluoresceins | 1 | 2013 | 48 | 0.030 |
Why?
| Constriction | 1 | 2013 | 45 | 0.030 |
Why?
| CREB-Binding Protein | 1 | 2013 | 28 | 0.030 |
Why?
| Protein Binding | 1 | 2020 | 2121 | 0.030 |
Why?
| Dihydrotestosterone | 1 | 2013 | 41 | 0.030 |
Why?
| Benzimidazoles | 1 | 2014 | 162 | 0.030 |
Why?
| Orchiectomy | 1 | 2013 | 67 | 0.030 |
Why?
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2013 | 42 | 0.030 |
Why?
| bcl-2-Associated X Protein | 1 | 2013 | 55 | 0.030 |
Why?
| Anxiety | 1 | 2020 | 966 | 0.030 |
Why?
| Hypothermia, Induced | 1 | 2013 | 76 | 0.030 |
Why?
| Primary Cell Culture | 1 | 2013 | 160 | 0.030 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 232 | 0.020 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 331 | 0.020 |
Why?
| Receptors, Androgen | 1 | 2013 | 147 | 0.020 |
Why?
| Corpus Striatum | 1 | 2013 | 159 | 0.020 |
Why?
| Clotrimazole | 1 | 2011 | 3 | 0.020 |
Why?
| Microinjections | 1 | 2011 | 86 | 0.020 |
Why?
| Adult | 1 | 2014 | 35576 | 0.020 |
Why?
| Lentivirus | 1 | 2011 | 53 | 0.020 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 431 | 0.020 |
Why?
| Aorta, Thoracic | 1 | 2013 | 262 | 0.020 |
Why?
| Culture Media | 1 | 2011 | 162 | 0.020 |
Why?
| RNA, Messenger | 1 | 2018 | 2708 | 0.020 |
Why?
| Cell Hypoxia | 1 | 2011 | 235 | 0.020 |
Why?
| Genetic Vectors | 1 | 2011 | 312 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2012 | 1038 | 0.020 |
Why?
| Cardiac Surgical Procedures | 1 | 2015 | 499 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2011 | 587 | 0.020 |
Why?
| Cell Culture Techniques | 1 | 2011 | 345 | 0.020 |
Why?
| Mutation | 1 | 2020 | 3717 | 0.020 |
Why?
| Etorphine | 1 | 2008 | 1 | 0.020 |
Why?
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2008 | 6 | 0.020 |
Why?
| Fluorescent Antibody Technique, Direct | 1 | 2008 | 10 | 0.020 |
Why?
| Oxymorphone | 1 | 2008 | 3 | 0.020 |
Why?
| Colforsin | 1 | 2008 | 50 | 0.020 |
Why?
| Radioligand Assay | 1 | 2008 | 48 | 0.020 |
Why?
| Egtazic Acid | 1 | 2008 | 41 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2012 | 1698 | 0.020 |
Why?
| Chelating Agents | 1 | 2008 | 68 | 0.020 |
Why?
| Oxycodone | 1 | 2008 | 43 | 0.020 |
Why?
| Electrophysiology | 1 | 2008 | 212 | 0.020 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2013 | 821 | 0.020 |
Why?
| Cyclic AMP | 1 | 2008 | 237 | 0.020 |
Why?
| G-Protein-Coupled Receptor Kinase 1 | 1 | 2006 | 1 | 0.020 |
Why?
| GTP-Binding Protein beta Subunits | 1 | 2006 | 11 | 0.020 |
Why?
| Vision, Ocular | 1 | 2006 | 35 | 0.020 |
Why?
| Mice, Inbred DBA | 1 | 2006 | 188 | 0.020 |
Why?
| Pediatrics | 1 | 2013 | 1052 | 0.020 |
Why?
| Recombinant Fusion Proteins | 1 | 2008 | 643 | 0.020 |
Why?
| Pregnancy | 1 | 2018 | 6402 | 0.020 |
Why?
| Aged | 1 | 2023 | 22103 | 0.010 |
Why?
| Light | 1 | 2006 | 360 | 0.010 |
Why?
| Treatment Outcome | 1 | 2015 | 10230 | 0.010 |
Why?
| Analgesics, Opioid | 1 | 2008 | 913 | 0.010 |
Why?
|
|
Quillinan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|